">Video of INEOS donates £100m to create new Oxford University institute to tackle antimicrobial resistanceThe new Ineos Oxford Institute will benefit from the internationally outstanding facilities and expertise of Oxford University, which played the key role in the origin of antibiotics following Fleming and Oxford’s discovery and development of penicillin in the last century. The Ineos Oxford Institute for AMR Research (IOI) will therefore focus on designing novel antimicrobials just for animals, as well as exploring new human drugs. Alongside its drug discovery work, the IOI intends to partner with other global leaders in the field of Antimicrobial Resistance (AMR) to raise awareness and promote responsible use of antimicrobial drugs. Surgeon David Sweetnam, Adviser to the Ineos Oxford Institute, said: 'The growing menace of bacterial resistance to antibiotics is one of the most underreported issues of our time. This new Institute, applying a model of reinvesting profit to drive fu
